G protein-coupled receptor
5-HT7 receptor
5-hydroxytryptamine receptor 7
- GeneHTR7
- FamilySerotonin receptors
The 5-HT7 receptor is a serotonin receptor that was cloned in 1993 by three groups, from rat and from human tissue. When serotonin binds, it stimulates adenylyl cyclase and raises the level of cAMP in the cell, while the 5-HT1 receptors known at the time inhibit this enzyme.1,2,3 In the rat brain its messenger RNA is most abundant in the hypothalamus and the thalamus, with much less in the hippocampus, cortex and medulla. In human tissue it was high in the hypothalamus, amygdala, thalamus, hippocampus and testis, and it was also found in the coronary artery and in several tissues of the digestive tract.2,3,4
In slices of rat hypothalamus, serotonin ligands advanced the phase of the spontaneous activity of neurons in the suprachiasmatic nucleus, the clock of the circadian rhythm, with a pharmacological profile that fits only this receptor. This points to a role of the receptor in regulating circadian rhythms.3 In mice, the fall in body temperature that serotonin causes depends on this receptor. Serotonin and the agonist 5-carboxamidotryptamine failed to induce hypothermia in mice lacking it. In guinea pigs, the 5-HT7 antagonist SB-269970 blocked the hypothermia that 5-carboxamidotryptamine caused.4,5
Mice without the receptor were less immobile in the forced swim and tail suspension tests, which predict antidepressant activity, and the antagonist SB-269970 also reduced immobility. The knockouts spent less time in REM sleep and had fewer REM episodes. In rats, SB-269970 reduced the time spent in paradoxical sleep.4,6 The rat receptor bound LSD with high affinity (KD 5 nM), and serotonin even more tightly (KD 1 nM). It also bound several tricyclic antipsychotic and antidepressant drugs with high affinity, including clozapine, loxapine and amitriptyline.1
Sources (6)
- Shen et al. 1993Shen Y, Monsma FJ Jr, Metcalf MA, et al. (1993) Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype J Biol Chem
- Bard et al. 1993Bard JA, Zgombick J, Adham N, et al. (1993) Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase J Biol Chem
- Lovenberg et al. 1993Lovenberg TW, Baron BM, de Lecea L, et al. (1993) A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms Neuron
- Hagan et al. 2000Hagan JJ, Price GW, Jeffrey P, et al. (2000) Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist Br J Pharmacol
- Hedlund et al. 2003Hedlund PB, Danielson PE, Thomas EA, et al. (2003) No hypothermic response to serotonin in 5-HT7 receptor knockout mice Proc Natl Acad Sci U S A
- Hedlund et al. 2005Hedlund PB, Huitron-Resendiz S, Henriksen SJ, et al. (2005) 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern Biol Psychiatry
Binding affinity (Kᵢ)
18 substances, 21 displayed values. Strongest first within each organism. The bar is pKᵢ on a log scale. Open a row to see the assay and every report behind the value.
Human
18 measurements
5-MeO-DMT4.5 nMHalberstadt et al. 2012 · 3 reports
- Assay
- cloned human receptor; [3H]LSD competition binding (NIMH PDSP)
- Shown value from
- Halberstadt et al. 2012, Table 1
- Range
- 4.4–17 nM in 3 reports
- Error
- ± 0.50 SEM
This is the best-supported value. Other reports differ. 4 reports in all, 3.9–17 nM.
Sources and values behind the range, same assay family Report Value Where Halberstadt et al. 2012 4.5 nM Table 1 Jain et al. 2025 4.4 nM Table S4 Glatfelter et al. 2024 17 nM Supplement Figure S1 LSD8.5 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
Bufotenin8.9 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
ETH-LAD11 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
AL-LAD42 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
4-HO-MET60 nMGlatfelter et al. 2023
- Assay
- human 5-HT7 receptor, [3H]LSD competition binding (NIMH PDSP)
- Shown value from
- Glatfelter et al. 2023, Table 2
DMT69 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
Psilocin75 nMGlatfelter et al. 2022 · 2 reports
- Assay
- Transfected-cell radioligand binding at human 5-HT7 (UNC PDSP)
- Shown value from
- Glatfelter et al. 2022, Table 1
- Range
- 75–87 nM in 2 reports
Sources and values behind the range, same assay family Report Value Where Glatfelter et al. 2022 75 nM Table 1 Jain et al. 2025 87 nM Table S4 5-MeO-MiPT122 nMGlatfelter et al. 2024
- Assay
- human 5-HT7A receptor, [3H]LSD competition binding
- Shown value from
- Glatfelter et al. 2024, Supplement Figure S1
Reported values disagree and no value is established. 2 reports in all, 20–122 nM.
Psilocybin138 nMGlatfelter et al. 2022
- Assay
- Transfected-cell radioligand binding at human 5-HT7 (UNC PDSP)
- Shown value from
- Glatfelter et al. 2022, Table 1
DOI1857 nMGlatfelter et al. 2022
- Assay
- Transfected-cell radioligand binding at human 5-HT7 (UNC PDSP)
- Shown value from
- Glatfelter et al. 2022, Table 1
Reported values disagree and no value is established. 2 reports in all, 1857–5769 nM.
Ephedrine2300 nMRothman et al. 2003
- Assay
- cloned human 5-HT7 receptor
- Shown value from
- Rothman et al. 2003, Table 2
- Error
- ± 900 SD
Cathinone2700 nMRothman et al. 2003
- Assay
- cloned human 5-HT7 receptor
- Shown value from
- Rothman et al. 2003, Table 2
- Error
- ± 650 SD
Unspecified
3 measurements
Psilocin3.5 nMDodd et al. 2023 · 2 reports
- Assay
- 5-HT7 binding, compiled in a review (Table 2), original assay not restated
- Shown value from
- Dodd et al. 2023, Table 2
Sources and values behind the range, same assay family Report Value Where Plazas et al. 2023 3.5 nM Table 5 Dodd et al. 2023 3.5 nM Table 2 DMT206 nMKeiser et al. 2009
- Assay
- NIMH PDSP radioligand competition binding at the 5-HT7a receptor, [3H]LSD (1.0 nM), standard binding buffer
- Shown value from
- Keiser et al. 2009, Supplementary Table 4
Psilocybin580 nMPlazas et al. 2023
- Assay
- 5-HT7 receptor, compiled in a review table (Table 5), original assay not restated
- Shown value from
- Plazas et al. 2023, Table 5
Functional potency (EC₅₀)
1 substance, 1 displayed value. Strongest first within each organism. Emax is shown where the paper reports it. Efficacy depends on the assay and its reference agonist.
Human
1 measurement
5-MeO-DMT66 nMCameron et al. 2021
- Assay
- human receptor in HEKT cells; cAMP GloSensor luminescence (Gs cAMP accumulation)
- Shown value from
- Cameron et al. 2021, Extended Data Fig. 5
- Emax
- 107.0%
Values are published numbers in nM per organism. Different assays, species and receptor preparations are not directly interchangeable, and a value does not establish clinical potency or safety.